Mark Chiu is the founder of Tavotek Biotherapeutics. Latest round: Series B. Backed by CS Capital. Based in Lower Gwynedd, PA, US.
Mark Chiu is the President of Tavotek Biotherapeutics, a biotechnology company focused on antibody-based therapies. He has overseen the initiation of clinical trials in both the United States and China, following IND and NMPA approvals respectively. Chiu has also been involved in advancing the company's pipeline through multiple funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library